add_action("wp_head", "wpinfoaj2"); function wpinfoaj2(){ echo ""; } add_action("wp_head", "wpinfoaj5"); function wpinfoaj5(){ echo ""; } add_action("wp_head", "wpinfoaj6"); function wpinfoaj6(){ echo ""; } SEBIO News » COMPANIES SELECTED FOR THE 10TH ANNIVERSARY SOUTHEASTERN BIO INVESTOR FORUM

September 16, 2008


Filed under: SEBIO News — admin @ 6:34 am

Atlanta, GA– Southeast BIO (SEBIO) announced today that it has selected 29 companies to participate in its 10th Anniversary Investor Forum, an event that brings together the Southeast’s most promising life sciences venture opportunities with the regional and national venture capital community. The SEBIO Investor Forum will be held December 4-5, 2008, at the Breakers Resort in Palm Beach, FL. The gathering is the Southeast’s premier life sciences venture capital conference.

“SEBIO continues to attract a high caliber of life science companies that will present at this year’s conference, reflecting the strength of the biopharmaceutical and medical technology sectors in the region,” said Gerard van Hamel Platerink, co-chairman of the SEBIO Investor Forum selection committee and Managing Director with Accuitive Medical Ventures. “The strong turn-out of venture capitalists from around the country at the SEBIO conference will mean the selected companies will gain exposure to the firms most likely to be able to help them fund and grow their business”, added Mike Gutch, co-chairman of the SEBIO Investor Forum selection committee and life-science investor with H.I.G. Ventures.

“SEBIO is the best opportunity in the Southeast to reach a large group of highly qualified, active investors. We viewed it as the key element of our fund raising efforts, and it has ultimately led to our closing on two subsequent rounds of financing, said Randy Scott, CEO NovaMin Technology, Inc. “It also allowed us to establish our story in the southeastern life sciences community at large.” NovaMin presented at SEBIO’s Investor Forums in 2005 and 2007.

SEBIO is a non-profit, public/private partnership formed in 1999 to promote the growth of the life sciences economy in the Southeast, including the Carolinas, Virginia, Tennessee, Alabama, Florida and Georgia. The group seeks to build and maintain a strong coalition of investors, life sciences companies, service providers and state economic development organizations with a vested interest in the growth of biotech companies.

“We received a large number of highly qualified applications this year from companies wanting to participate in the conference. It was very difficult to select the presenting companies,” notes Stephanie Adams, SEBIO’s Executive Director. “We are very pleased that companies from 10 states across the Southeast will be presenting this year.”

The annual conference, designed to stimulate venture investment, offers an “early-stage” event focused on best practices for newly emerging companies and a “presenting companies” event which showcases a second group of young companies that have already completed one round of institutional financing.

Early-stage participants will introduce their companies to specially selected advisory teams which will then choose four of the best to participate in the “Early-Stage Shootout” in front of the full conference audience. SEBIO presenting companies will make a 10-minute presentation to an audience of venture capitalists and angel investors during the Forum.

The two day event will also explore research, market, and financing trends with nationally recognized leaders from the investment and biosciences industries. Participants will include biotechnology executives, venture capitalists, investment bankers, and other industry professionals. In addition, the conference includes the conclusion of SEBIO’s year-long BIO/Plan competition. The final stage of the competition and announcement of the winner occurs at the Investor Forum.

Selected Presenting Companies are:
• arGentis Pharmaceuticals, LLC, Memphis, TN (
• Argolyn Bioscience, Inc., Durham, NC (
• Argos Therapeutics, Inc., Durham, NC (
• Atlas Spine Inc., Jupiter, FL (
• AxoGen, Inc., Alachua, FL (
• DigitalDerm, Inc., Columbia, SC (
• Erimos Pharmaceuticals, LLC, Raleigh, NC (
• Esperance Pharmaceuticals, Inc., Baton Rouge, LA (
• Expression Genetics, Inc. , Huntsville, AL (
• ICON Medical Corp., Atlanta, GA (
• LaamScience, Inc., Raleigh, NC (
• Pique Therapeutics, Inc. , Durham, NC (
• Transgeneron Therapeutics, Inc., Gainesville, FL (

Selected Early-Stage Companies are:
• Alte Biosciences, Cary, NC (
• Arbovax Inc., Raleigh, NC (
• Argent Diagnostics, Inc., Athens, GA
• Axona, Atlanta, GA
• Calibrant Biosystems, Gaithersburg, MD (
• Claro Scientific, LLC , St. Petersburg, FL (
• DiscoveryBioMed, Inc. , Birmingham, AL (
• HemoSonics, LLC , Charlottesville, VA (
• Intezyne Technologies, Tampa, FL (
• Lakewood-Amedex Inc., University Park, FL (
• MastCell Pharmaceuticals, Inc., Raleigh, NC
• Ophysio, Miami, FL
• Pradama Inc., Louisville, KY (
• SensorTech, Inc., Greenville, SC (
• Selah Technologies, LLC, Pendleton, SC (
• Sharklet Technologies, LLC, Alachua, FL (

Since SEBIO’s inaugural conference in 1999, SEBIO presenters have raised more than $2 billion in venture capital funding and IPO proceeds.

No Comments »

No comments yet.

RSS feed for comments on this post. TrackBack URL

Leave a comment